Phase I/II study of weekly intravenous estramustine phosphate in combination with paclitaxel and carboplatin in patients with advanced prostate cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Carboplatin; Estramustine; Paclitaxel
- Indications Prostate cancer
- Focus Therapeutic Use
- 24 Jun 2013 Biomarkers information updated
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Oct 2005 New trial record.